Lizhen He

4.7k total citations · 1 hit paper
85 papers, 4.0k citations indexed

About

Lizhen He is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Lizhen He has authored 85 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Biomedical Engineering, 30 papers in Materials Chemistry and 27 papers in Molecular Biology. Recurrent topics in Lizhen He's work include Nanoplatforms for cancer theranostics (46 papers), Nanoparticle-Based Drug Delivery (18 papers) and Selenium in Biological Systems (17 papers). Lizhen He is often cited by papers focused on Nanoplatforms for cancer theranostics (46 papers), Nanoparticle-Based Drug Delivery (18 papers) and Selenium in Biological Systems (17 papers). Lizhen He collaborates with scholars based in China, Hong Kong and United States. Lizhen He's co-authors include Tianfeng Chen, Yanyu Huang, Guanning Huang, Yuanyuan You, Wenjie Zheng, Haoqiang Lai, Hongxing Liu, Bin Ma, Xinxin Liu and Yum-Shing Wong and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Lizhen He

82 papers receiving 4.0k citations

Hit Papers

Highly bioactive zeolitic imidazolate framework-8–capped ... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizhen He China 36 1.9k 1.4k 981 967 669 85 4.0k
Liang Gao China 39 1.2k 0.6× 1.6k 1.1× 595 0.6× 1.0k 1.1× 181 0.3× 123 4.3k
Yangzhong Liu China 40 1.6k 0.8× 1.7k 1.2× 905 0.9× 2.1k 2.2× 273 0.4× 165 5.2k
Orazio Vittorio Italy 32 1.1k 0.6× 816 0.6× 832 0.8× 606 0.6× 203 0.3× 108 3.1k
Peng Zhang China 42 2.0k 1.0× 977 0.7× 1.1k 1.2× 1.4k 1.5× 63 0.1× 219 5.5k
Wenxia Gao China 43 1.3k 0.7× 1.5k 1.1× 1.1k 1.2× 796 0.8× 118 0.2× 168 5.0k
Yi Hu China 31 917 0.5× 558 0.4× 570 0.6× 1.2k 1.2× 152 0.2× 90 2.7k
Badri N. Pandey India 34 830 0.4× 613 0.4× 756 0.8× 815 0.8× 82 0.1× 112 3.2k
Fei Yan China 43 1.2k 0.6× 602 0.4× 553 0.6× 2.5k 2.5× 110 0.2× 202 5.4k

Countries citing papers authored by Lizhen He

Since Specialization
Citations

This map shows the geographic impact of Lizhen He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizhen He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizhen He more than expected).

Fields of papers citing papers by Lizhen He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizhen He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizhen He. The network helps show where Lizhen He may publish in the future.

Co-authorship network of co-authors of Lizhen He

This figure shows the co-authorship network connecting the top 25 collaborators of Lizhen He. A scholar is included among the top collaborators of Lizhen He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizhen He. Lizhen He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Guanning, et al.. (2025). Exploring the Neuroprotective Role of Selenium: Implications and Perspectives for Central Nervous System Disorders. Exploration. 5(4). e20240415–e20240415. 4 indexed citations
2.
Liu, Ting, Zhiming Lin, Xi Zhang, et al.. (2025). Targeting Nanotherapeutics for Highly Efficient Diagnosis and Treatment of Systemic Lupus Erythematosus through Regulation of Immune Response. Small Science. 5(5). 2400521–2400521. 2 indexed citations
3.
Hu, Xiaoli, Zhongwen Yuan, Guanning Huang, et al.. (2025). High‐Valence Selenium Nanotherapeutics Downregulates MUC16 to Drive Precise Ovarian Cancer Therapy through Redox Perturbation. Advanced Functional Materials. 35(22). 4 indexed citations
4.
5.
He, Lizhen, Zushuang Xiong, & Tianfeng Chen. (2025). Selenium nanomedicine: From basic science to clinical applications. Chem. 11(3). 102493–102493. 2 indexed citations
6.
He, Lizhen, et al.. (2024). Autophagy‐Inducing MoO3‐x Nanowires Boost Photothermal‐Triggered Cancer Immunotherapy. Angewandte Chemie International Edition. 63(28). e202404822–e202404822. 10 indexed citations
8.
Huang, Wei, Lizhen He, Shiqing Nie, et al.. (2023). Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment. Nano Today. 50. 101819–101819. 16 indexed citations
9.
He, Lizhen, Jianfu Zhao, Hongjun Li, et al.. (2023). Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy. Advanced Science. 10(8). e2202519–e2202519. 36 indexed citations
10.
Liu, Yanfang, Tianyuan Zhang, Xing Zou, et al.. (2023). Penumbra-targeted CircOGDH siRNA-loaded nanoparticles alleviate neuronal apoptosis in focal brain ischaemia. Stroke and Vascular Neurology. 9(2). 134–144. 13 indexed citations
11.
Yuan, Zhongwen, Xinxin Liu, Guanning Huang, et al.. (2022). In situ-transition nanozyme triggered by tumor microenvironment boosts synergistic cancer radio-/chemotherapy through disrupting redox homeostasis. Biomaterials. 287. 121620–121620. 59 indexed citations
12.
Zou, Binhua, Zushuang Xiong, Lizhen He, & Tianfeng Chen. (2022). Reversing breast cancer bone metastasis by metal organic framework-capped nanotherapeutics via suppressing osteoclastogenesis. Biomaterials. 285. 121549–121549. 58 indexed citations
13.
He, Lizhen, Li‐Xuan Cai, Meng-Hua Li, et al.. (2020). Designing a highly stable coordination-driven metallacycle for imaging-guided photodynamic cancer theranostics. Chemical Science. 11(30). 7940–7949. 26 indexed citations
14.
Wang, Zhuo, Lizhen He, Bingqing Liu, et al.. (2020). Coordination-Assembled Water-Soluble Anionic Lanthanide Organic Polyhedra for Luminescent Labeling and Magnetic Resonance Imaging. Journal of the American Chemical Society. 142(38). 16409–16419. 106 indexed citations
15.
Chang, Yanzhou, et al.. (2020). Designing intelligent nano-bomb with on-demand site-specific drug burst release to synergize with high-intensity focused ultrasound cancer ablation. Journal of Controlled Release. 331. 270–281. 41 indexed citations
16.
17.
Gao, Peng, Chaoming Mei, Lizhen He, et al.. (2018). Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer. Drug Delivery. 25(1). 1811–1825. 25 indexed citations
18.
Huang, Hao, Lizhen He, Wenhua Zhou, et al.. (2018). Stable black phosphorus/Bi2O3 heterostructures for synergistic cancer radiotherapy. Biomaterials. 171. 12–22. 105 indexed citations
19.
Fu, Xiaoyan, Yahui Yang, Xiaoling Li, et al.. (2016). RGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathway. Nanomedicine Nanotechnology Biology and Medicine. 12(6). 1627–1639. 114 indexed citations
20.
Huang, Yanyu, Lizhen He, Wen Liu, et al.. (2013). Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials. 34(29). 7106–7116. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026